Syngenta has announced the launch of the EPIVIO brand family, a range of new biostimulants that address abiotic stresses through seed treatment. Over the last five years Syngenta has developed abiotic stress management testing capabilities to simulate drought, heat, cold and nutrient stresses. Seed treatment products resulting from this R&D platform are now commercialized under the EPIVIO brand in combination with other Seedcare products to improve plant growth while addressing difficult-to-control pathogens, insects and nematodes.
EPIVIO products stimulate seedling development by providing micronutrients and biostimulant compounds to the plant and by activating soil microflora. The resulting natural symbiotic cycle leads to stress-tolerant plants. Extensive field trials in Latin America have demonstrated yield benefits averaging 5 percent to soybean growers working under a broad range of conditions.
“Syngenta has always been at the forefront in delivering innovation through seed applied fungicides, insecticides and nematicides–as well as through our focus on root health,” said Ioana Tudor, Syngenta global head of Seedcare. “We see soil productivity as a major new opportunity to make crops more efficient, stress-tolerant and higher yielding”
First sales of EPIVIO will take place this year in Brazil for soybean and in China for corn. EPIVIO will then be rapidly expanded to additional crops and geographies.